AiCure Revenue and Competitors

Location

$52.8M

Total Funding

Estimated Revenue & Valuation

  • AiCure's estimated annual revenue is currently $10.9M per year.(i)
  • AiCure received $12.2M in venture funding in January 2016.
  • AiCure's estimated revenue per employee is $140,000
  • AiCure's total funding is $52.8M.

Employee Data

  • AiCure has 78 Employees.(i)
  • AiCure grew their employee count by -21% last year.

AiCure's People

NameTitleEmail/Phone
1
CEOReveal Email/Phone
2
Chief Marketing OfficerReveal Email/Phone
3
General Counsel, Chief Administrative OfficerReveal Email/Phone
4
SVP Product ManagementReveal Email/Phone
5
VP, Commercial Development and Strategic SolutionsReveal Email/Phone
6
VP People OperationsReveal Email/Phone
7
SVP OperationsReveal Email/Phone
8
VP People OperationsReveal Email/Phone
9
Director Engineering, MobileReveal Email/Phone
10
Principal Engineer, Director Engineering Backend/Full Stack at AiCureReveal Email/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$69.2M3892%$251.1M$1.7B
#2
$12.9M9219%$11.5MN/A
Add Company

What Is AiCure?

AiCure's intelligent medical assistant, IMA, leverages a visual recognition platform to monitor patient progress. IMA provides visual dose confirmation, interactive patient support and engagement, and visual diagnostic capabilities. With almost 100 patents awarded or pending and funding from leading institutional investors and the National Institutes of Health, the platform has been validated to improve patient behavior in randomized controlled trials. AiCure is revolutionizing drug development and clinical care by ensuring that high quality treatments reach the patients that need them most. Intelligent observation leads to better care.

keywords:Biotechnology,Enterprise Software,Health It,Healthcare,Healthcare Providers,Human Resources Hr,Pharmaceuticals

$52.8M

Total Funding

78

Number of Employees

$10.9M

Revenue (est)

-21%

Employee Growth %

N/A

Valuation

N/A

Accelerator

AiCure News

2022-04-06 - Insights on the Virtual Clinical Trials US Market to 2027 - Featuring AiCure, Covance and Everest Global Among Others - ResearchAndMarkets.com

Insights on the Virtual Clinical Trials US Market to 2027 - Featuring AiCure, Covance and Everest Global Among Others - ResearchAndMarkets.

2022-04-06 - AiCure Bolsters Global Presence and Team to Expand its ...

NEW YORK, April 5, 2022 /PRNewswire/ -- AiCure, an AI and advanced data analytics company focused on improving clinical trials, today announced...

2020-12-08 - AiCure Launches New Data Dashboards to Improve Visibility into Patient Behavior and Site Performance

NEW YORK, Dec. 8, 2020 /PRNewswire/ -- AiCure, an AI and advanced data analytics company focused on improving clinical trials, today introduced AiCure Data Intelligence, its next-generation data dashboard to empower sponsors with advanced visibility into each trial's progress via a single, hol ...

2020-10-28 - AiCure Launches Open Science Framework to Advance Digital Biomarker Development at CNS Summit 2020

NEW YORK, Oct. 28, 2020 /PRNewswire/ -- AiCure, an AI and advanced data analytics company focused on improving clinical trials, today introduced OpenDBM, an open-source version of its computer vision and AI-powered digital biomarker platform, at CNS Summit 2020. The platform's transparent fram ...

2020-04-28 - AiCure Launches Platform to Remotely Capture Digital Biomarkers in Clinical Trials

What You Should Know: – AiCure launches digital biomarker platform to remotely detect subtle changes in a patient’s condition, leverages computer vision and AI to gather and analyze visual and auditory cues directly through the patient’s smartphone camera. – AiCure appoints Ed Ikeguchi, M.D. a ...

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$10.9M7850%N/A
#2
$10.9M78-33%$18.2M
#3
$10.1M785%$66M
#4
$11.3M784%N/A
#5
$15M788%N/A

AiCure Funding

DateAmountRoundLead InvestorsReference
2016-01-12$12.2MANew Leaf Venture PartnersArticle